ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
China Kanghui Holdings American Depositary Shares (Each Representing Six Ordinary Shares, $0.001 Par Value)

China Kanghui Holdings American Depositary Shares (Each Representing Six Ordinary Shares, $0.001 Par Value) (KH)

30.60
0.00
(0.00%)
Closed July 30 4:00PM
30.60
0.00
( 0.00% )
Pre Market: 8:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
30.60
Bid
-
Ask
-
Volume
0.00
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
30.60
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

KH Latest News

Brickell Biotech to Report Second Quarter 2020 Financial Results and Provide a Corporate Update on August 12, 2020

BOULDER, Colo., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated...

Brickell Biotech, Inc. Announces Pricing of $20.1 Million Underwritten Public Offering

BOULDER, Colo., June 17, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated...

Brickell Biotech Announces Positive Phase 3 Pivotal Study Results for Sofpironium Bromide in Japan Released by Development Pa...

Data based on registration study in Japan of sofpironium bromide gel, 5% in patients with primary axillary hyperhidrosis All primary and secondary endpoints were met and achieved statistical...

Brickell Biotech Reports First Quarter 2020 Financial Results and Provides Corporate Update

BOULDER, Colo., May 13, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated...

Brickell Biotech to Report First Quarter 2020 Financial Results on May 13, 2020

BOULDER, Colo., May 04, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated...

Brickell Biotech Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

BOULDER, Colo., March 18, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated...

Brickell Biotech to Report Fourth Quarter and Full Year 2019 Financial Results on March 18, 2020

BOULDER, Colo., March 09, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated...

Brickell Biotech Announces Late-Breaking Oral Presentation at 2020 American Academy of Dermatology Annual Meeting by its Asia...

BOULDER, Colo., March 04, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated...

Brickell Biotech Announces Publication of its U.S. Phase 2b Study Results for Sofpironium Bromide in Patients with Primary Ax...

BOULDER, Colo., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated...

Brickell Biotech Announces Settlement of Dispute with Bodor Labs and Entry into Equity Funding Agreements

BOULDER, Colo., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. and its subsidiary (collectively, “Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VSTVistra Corp
$ 80.25
(16.30%)
152.09k
CPSCooper Standard Holdings Inc
$ 16.00
(11.42%)
2
ACELAccel Entertainment Inc
$ 12.22
(10.29%)
96
SKESkeena Resources Ltd
$ 6.99
(9.91%)
50
HVT.AHaverty Furniture Companies Inc
$ 30.07
(9.66%)
3
PENPenumbra Inc
$ 148.33
(-14.30%)
15.42k
DESPDespegar com Corp
$ 10.30
(-11.82%)
44
CCKCrown Holdings Inc
$ 78.14
(-10.55%)
1
CYHCommunity Health Systems Inc
$ 4.62
(-10.47%)
14
APAmpco Pittsburgh Corp
$ 1.38
(-9.80%)
119
CCLCarnival Corp
$ 17.42
(1.75%)
2.77M
LUMNLumen Technologies Inc
$ 2.63
(-1.50%)
1.86M
LVSLas Vegas Sands Corp
$ 39.60
(0.33%)
1.52M
BTIBritish American Tobacco PLC
$ 35.63
(-0.45%)
1.36M
NIONIO Inc
$ 4.49
(1.58%)
963.74k

KH Discussion

View Posts
SWINGTRADER59 SWINGTRADER59 9 years ago
This is actually creating good buying opportunities!
👍️0
SWINGTRADER59 SWINGTRADER59 9 years ago
What a bloody day today... Thanks China
👍️0
babuneel26 babuneel26 12 years ago
List of Stocks Suddenly Spurt on Unusual Volume ( BYFC, KH, MDRX, CUR )
Read More
👍️0
Penny Roger$ Penny Roger$ 12 years ago
China Kanghui Holdings Misses Where it Counts
DailyFinance - May 25, 2012
China Kanghui Holdings (NYS: KH) reported earnings on May 24. Here are the numbers you need to know. The 10-second takeawayFor.

http://www.dailyfinance.com/2012/05/25/china-kanghui-holdings-misses-where-it-counts/
👍️0
Penny Roger$ Penny Roger$ 12 years ago
China Kanghui Holdings Reports Fourth Quarter and Full Year 2011 Financial Results

http://ih.advfn.com/p.php?pid=nmona&article=51669596&symbol=KH
👍️0
Penny Roger$ Penny Roger$ 12 years ago
~ Monday! $KH ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $KH ~ Earnings expected on Monday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=KH&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=KH&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=KH
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=KH#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=KH+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=KH
Finviz: http://finviz.com/quote.ashx?t=KH
~ BusyStock: http://busystock.com/i.php?s=KH&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=KH >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.
👍️0
Penny Roger$ Penny Roger$ 12 years ago
China Kanghui Holdings is a holding company and conducts all of its business through its two wholly owned subsidiaries in China, Changzhou Kanghui Medical Innovation Co., Ltd. (Changzhou Kanghui) and Beijing Libeier. The Company is a domestic developer, manufacturer and marketer of orthopedic implants in People’s Republic of China. The Company’s orthopedic implant brands are Kanghui and Libeier. It sells two lines of orthopedic implant products, trauma and spine. Its major trauma products, used in the surgical treatment of bone fractures, include a range of nails, plates and screws. Its major spine products, used in the surgical treatment of spine disorders, include screws, meshes, interbody cages and fixation systems. On July 31, 2008, we acquired 100% of the equity interests of Beijing Libeier. On July 31, 2009, the Company established Shanghai Zhikang Medical Devices Co., Ltd. (Shanghai Zhikang), which is wholly owned by Changzhou Kanghui.

http://www.google.com/finance?q=KH
👍️0